{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T22:55:24Z","timestamp":1772751324018,"version":"3.50.1"},"reference-count":33,"publisher":"Tech Science Press","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["oncol res"],"published-print":{"date-parts":[[2018,7,5]]},"abstract":"<jats:p>Ailanthone (AIL) is a quassinoid isolated from the traditional Chinese medicinal herb <jats:italic>Ailanthus altissima<\/jats:italic>. The antitumor activities of AIL have been reported in several cancers. The purpose of the present study was to explore the effect of AIL on vestibular schwannomas (VSs).\n Various concentrations of AIL (0\u20101 \u03bcM) were used to treat human primary VS cells, and then cell viability, proliferation, apoptosis, and autophagy were assessed. Expression of miR-21 in VS cells was altered by miRNA transfection. The functional actions of AIL on miR-21 dysregulated\n cells were also assessed. AIL significantly reduced the viability of VS cells, and the IC<jats:sub>50<\/jats:sub> value was 0.48\u2009\u00b1\u20090.023 \u03bcM. In response to 0.6 \u03bcM AIL, BrdU<jats:sup>+<\/jats:sup> cell rate and cyclin D1 expression were reduced, apoptotic cell rate was increased, caspase\n 3 and caspase 9 were cleaved, Beclin-1 and LC3-II were accumulated, and p62 was downregulated. miR-21 was lowly expressed in AIL-treated cells, and AIL-induced apoptosis and autophagy were attenuated by miR-21 overexpression. In addition, AIL downregulated Ras and Raf and deactivated MEK,\n ERK, mTOR, and p70S6K, while the downregulation and deactivation induced by AIL were reversed by miR-21 overexpression. To conclude, AIL inhibited VS cell proliferation and induced apoptosis and autophagy. The antitumor activities of AIL in VS cells were realized possibly via downregulation of miR-21 and blocking the Ras\/Raf\/MEK\/ERK and mTOR pathways.<\/jats:p>","DOI":"10.3727\/096504018x15149775533331","type":"journal-article","created":{"date-parts":[[2018,1,4]],"date-time":"2018-01-04T01:07:52Z","timestamp":1515028072000},"page":"941-948","source":"Crossref","is-referenced-by-count":29,"title":["Ailanthone Promotes Human Vestibular Schwannoma Cell Apoptosis and Autophagy by Downregulation of miR-21"],"prefix":"10.32604","volume":"26","author":[{"given":"Peizhen","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Otorhinolaryngology, Linyi People\u2019s Hospital, Linyi, Shandong, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dezhong","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, Linyi People\u2019s Hospital, Linyi, Shandong, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Linyi People\u2019s Hospital, Linyi, Shandong, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"17807","reference":[{"issue":"1","key":"b1","doi-asserted-by":"crossref","first-page":"5470","DOI":"10.1038\/s41598-017-05769-0","article-title":"Differential NF2 gene status in sporadic vestibular schwannomas and its prognostic impact on tumour growth patterns","volume":"7","year":"2017","journal-title":"Sci Rep."},{"issue":"1","key":"b2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00129492-200501000-00016","article-title":"Incidence of vestibular schwannoma and neurofibromatosis 2 in the North West of England over a 10-year period: Higher incidence than previously thought","volume":"26","year":"2005","journal-title":"Otol Neurotol."},{"issue":"6","key":"b3","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s00701-017-3164-6","article-title":"Stereotactic radiosurgery vs. fractionated radiotherapy for tumor control in vestibular schwannoma patients: A systematic review","volume":"159","year":"2017","journal-title":"Acta Neurochir. (Wien)"},{"issue":"1","key":"b4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3171\/jns.2005.102.1.0006","article-title":"Long-term hearing preservation after surgery for vestibular schwannoma","volume":"102","year":"2005","journal-title":"J Neurosurg."},{"issue":"3","key":"b5","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0196-0709(00)80054-X","article-title":"Prognostic factors for hearing preservation in vestibular schwannoma surgery","volume":"21","year":"2000","journal-title":"Am J Otol."},{"issue":"1","key":"b6","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ptr.2650010105","article-title":"Plants as a source of antimalarial drugs 5. Activities of Ailanthus altissima stem constituents and of some related quassinoids","volume":"1","year":"1987","journal-title":"Phytother Res."},{"issue":"5","key":"b7","doi-asserted-by":"crossref","first-page":"6821","DOI":"10.3892\/mmr.2017.7491","article-title":"Ailanthone induces G2\/M cell cycle arrest and apoptosis of SGC7901 human gastric cancer cells","volume":"16","year":"2017","journal-title":"Mol Med Rep."},{"key":"b8","doi-asserted-by":"crossref","first-page":"13122","DOI":"10.1038\/ncomms13122","article-title":"Ailanthone targets p23 to overcome MDV3100 resistance in castration-resistant prostate cancer","volume":"7","year":"2016","journal-title":"Nat Commun."},{"issue":"1","key":"b9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40880-017-0194-7","article-title":"Ailanthone: A new potential drug for castration-resistant prostate cancer","volume":"36","year":"2017","journal-title":"Chin J Cancer"},{"key":"b10","doi-asserted-by":"crossref","first-page":"16185","DOI":"10.1038\/srep16185","article-title":"Ailanthone inhibits Huh7 cancer cell growth via cell cycle arrest and apoptosis in vitro and in vivo","volume":"5","year":"2015","journal-title":"Sci Rep."},{"issue":"2","key":"b11","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: Genomics, biogenesis, mechanism, and function","volume":"116","year":"2004","journal-title":"Cell"},{"issue":"4","key":"b12","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s12253-016-0184-0","article-title":"Entangling relation of micro RNA-let7, miRNA-200 and miRNA-125 with various cancers","volume":"23","year":"2017","journal-title":"Pathol Oncol Res."},{"key":"b13","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12935-015-0185-1","article-title":"MicroRNA (miRNA) in cancer","volume":"15","year":"2015","journal-title":"Cancer Cell Int."},{"issue":"1","key":"b14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4161\/cbt.11.1.13965","article-title":"Deregulated expression of sprouty2 and microRNA-21 in human colon cancer: Correlation with the clinical stage of the disease","volume":"11","year":"2011","journal-title":"Cancer Biol Ther."},{"issue":"11","key":"b15","doi-asserted-by":"crossref","first-page":"4944","DOI":"10.1182\/blood-2006-12-062398","article-title":"Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia","volume":"109","year":"2007","journal-title":"Blood"},{"issue":"6","key":"b16","doi-asserted-by":"crossref","first-page":"e65868","DOI":"10.1371\/journal.pone.0065868","article-title":"Global profiling in vestibular schwannomas shows critical deregulation of microRNAs and upregulation in those included in chromosomal region 14q32","volume":"8","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"b17","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1097\/MAO.0b013e3181f20655","article-title":"MicroRNA-21 overexpression contributes to vestibular schwannoma cell proliferation and survival","volume":"31","year":"2010","journal-title":"Otol Neurotol."},{"issue":"6","key":"b18","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/glia.20316","article-title":"Constitutive neuregulin-1\/ErbB signaling contributes to human vestibular schwannoma proliferation","volume":"53","year":"2006","journal-title":"Glia"},{"issue":"6","key":"b19","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/MLG.0b013e318163f920","article-title":"Effects of ErbB2 signaling on the response of vestibular schwannoma cells to gamma-irradiation","volume":"118","year":"2008","journal-title":"Laryngoscope"},{"issue":"5","key":"b20","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1101\/gad.7.5.812","article-title":"Cyclin D1 is a nuclear protein required for cell cycle progression in G1","volume":"7","year":"1993","journal-title":"Genes Dev."},{"key":"b21","doi-asserted-by":"crossref","first-page":"S216","DOI":"10.1038\/sj.cdd.4401534","article-title":"Quassinoids can induce mitochondrial membrane depolarisation and caspase 3 activation in human cells","volume":"11","year":"2004","journal-title":"Cell Death Differ."},{"issue":"11","key":"b22","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1021\/tx500264s","article-title":"Toxic metals and autophagy","volume":"27","year":"2014","journal-title":"Chem Res Toxicol."},{"issue":"14","key":"b23","doi-asserted-by":"crossref","first-page":"23675","DOI":"10.18632\/oncotarget.15644","article-title":"Role of microRNA-21 in radiosensitivity in non-small cell lung cancer cells by targeting PDCD4 gene","volume":"8","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"b24","first-page":"953","article-title":"miRNA-21 promotes proliferation and invasion of triple-negative breast cancer cells through targeting PTEN","volume":"9","year":"2017","journal-title":"Am J Transl Res."},{"issue":"6","key":"b25","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jcma.2017.01.003","article-title":"MicroRNA-21 promotes perineural invasion and impacts survival in patients with oral carcinoma","volume":"80","year":"2017","journal-title":"J Chin Med Assoc."},{"issue":"1","key":"b26","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.apjtm.2016.09.011","article-title":"miR-21 targets and inhibits tumor suppressor gene PTEN to promote prostate cancer cell proliferation and invasion: An experimental study","volume":"10","year":"2017","journal-title":"Asian Pac J Trop Med."},{"issue":"1","key":"b27","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3892\/mmr.2016.5971","article-title":"MicroRNA21 promotes migration and invasion of glioma cells via activation of Sox2 and betacatenin signaling","volume":"15","year":"2017","journal-title":"Mol Med Rep."},{"issue":"1","key":"b28","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s12957-016-1028-9","article-title":"Overexpression of microRNA-21 strengthens stem cell-like characteristics in a hepatocellular carcinoma cell line","volume":"14","year":"2016","journal-title":"World J Surg Oncol."},{"issue":"3","key":"b29","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1007\/s13277-014-2824-x","article-title":"NSK-01105 inhibits proliferation and induces apoptosis of prostate cancer cells by blocking the Raf\/MEK\/ERK and PI3K\/Akt\/mTOR signal pathways","volume":"36","year":"2015","journal-title":"Tumour Biol."},{"issue":"2","key":"b30","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.molimm.2014.02.004","article-title":"Regulation of T lymphocyte activation by microRNA-21","volume":"59","year":"2014","journal-title":"Mol Immunol."},{"issue":"3","key":"b31","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ccr.2010.08.013","article-title":"Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21","volume":"18","year":"2010","journal-title":"Cancer Cell"},{"issue":"9","key":"b32","doi-asserted-by":"crossref","first-page":"12161","DOI":"10.1007\/s13277-016-5073-3","article-title":"MiR-21 modulates radiosensitivity of cervical cancer through inhibiting autophagy via the PTEN\/Akt\/HIF-1alpha feedback loop and the Akt-mTOR signaling pathway","volume":"37","year":"2016","journal-title":"Tumour Biol."},{"key":"b33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.biopha.2015.11.005","article-title":"Silencing of microRNA-21 confers the sensitivity to tamoxifen and fulvestrant by enhancing autophagic cell death through inhibition of the PI3K-AKT-mTOR pathway in breast cancer cells","volume":"77","year":"2016","journal-title":"Biomed Pharmacother."}],"container-title":["Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.techscience.com\/uploads\/attached\/file\/20240527\/20240527092949_81151.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T21:36:41Z","timestamp":1733521001000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.techscience.com\/or\/v26n6\/56707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,5]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,7,5]]}},"alternative-id":["0965-0407(20180705)26:6L.941;1-"],"URL":"https:\/\/doi.org\/10.3727\/096504018x15149775533331","relation":{},"ISSN":["0965-0407"],"issn-type":[{"value":"0965-0407","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7,5]]}}}